Fatima Teixeira-Clerc

12.5k total citations · 1 hit paper
33 papers, 3.3k citations indexed

About

Fatima Teixeira-Clerc is a scholar working on Pharmacology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Fatima Teixeira-Clerc has authored 33 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 15 papers in Pathology and Forensic Medicine and 15 papers in Epidemiology. Recurrent topics in Fatima Teixeira-Clerc's work include Cannabis and Cannabinoid Research (16 papers), Alcohol Consumption and Health Effects (13 papers) and Liver Disease Diagnosis and Treatment (12 papers). Fatima Teixeira-Clerc is often cited by papers focused on Cannabis and Cannabinoid Research (16 papers), Alcohol Consumption and Health Effects (13 papers) and Liver Disease Diagnosis and Treatment (12 papers). Fatima Teixeira-Clerc collaborates with scholars based in France, Germany and Belgium. Fatima Teixeira-Clerc's co-authors include Sophie Lotersztajn, Ariane Mallat, Boris Julien, Pascale Grenard, Vanessa Deveaux, Liying Li, Andreas Zimmer, Jeanne Tran Van Nhieu, Alexandre Louvet and Marie-Noële Chobert and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Gastroenterology.

In The Last Decade

Fatima Teixeira-Clerc

32 papers receiving 3.2k citations

Hit Papers

M2 Kupffer cells promote ... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease
    2013 452 citations Fatima Teixeira-Clerc, Alexandre Louvet et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatima Teixeira-Clerc France 21 1.4k 1.2k 803 773 597 33 3.3k
Águeda González‐Rodríguez Spain 30 1.4k 1.0× 148 0.1× 303 0.4× 1.3k 1.7× 449 0.8× 80 3.0k
Zongxian Cao United States 23 345 0.2× 502 0.4× 178 0.2× 959 1.2× 210 0.4× 30 2.4k
Béla Horváth United States 21 238 0.2× 878 0.7× 118 0.1× 942 1.2× 373 0.6× 42 2.8k
Giulio Ceolotto Italy 33 461 0.3× 243 0.2× 213 0.3× 1.3k 1.7× 736 1.2× 105 3.2k
Gerhard P. Püschel Germany 26 485 0.3× 403 0.3× 165 0.2× 767 1.0× 288 0.5× 70 2.0k
Philippe Gervois France 27 929 0.7× 294 0.2× 120 0.1× 2.6k 3.4× 627 1.1× 38 4.2k
Shivendra D. Shukla United States 31 557 0.4× 194 0.2× 95 0.1× 1.4k 1.8× 266 0.4× 80 2.7k
Ludger Scheja Germany 30 1.7k 1.2× 185 0.2× 156 0.2× 1.7k 2.2× 619 1.0× 61 4.5k
Mohammed Qatanani United States 19 904 0.6× 118 0.1× 266 0.3× 1.1k 1.4× 423 0.7× 22 3.3k
Tony Jourdan United States 24 342 0.2× 1.0k 0.8× 61 0.1× 497 0.6× 558 0.9× 38 2.0k

Countries citing papers authored by Fatima Teixeira-Clerc

Since Specialization
Citations

This map shows the geographic impact of Fatima Teixeira-Clerc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatima Teixeira-Clerc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatima Teixeira-Clerc more than expected).

Fields of papers citing papers by Fatima Teixeira-Clerc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatima Teixeira-Clerc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatima Teixeira-Clerc. The network helps show where Fatima Teixeira-Clerc may publish in the future.

Co-authorship network of co-authors of Fatima Teixeira-Clerc

This figure shows the co-authorship network connecting the top 25 collaborators of Fatima Teixeira-Clerc. A scholar is included among the top collaborators of Fatima Teixeira-Clerc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatima Teixeira-Clerc. Fatima Teixeira-Clerc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahnou, Nazim, Abdelhakim Ahmed‐Belkacem, Anne Hulin, et al.. (2023). The novel cyclophilin inhibitor C105SR reduces hepatic ischaemia–reperfusion injury via mitoprotection. JHEP Reports. 5(11). 100876–100876. 3 indexed citations
2.
Chobert, Marie-Noële, Vanessa Démontant, Guillaume Gricourt, et al.. (2021). Macrophage autophagy protects against hepatocellular carcinogenesis in mice. Scientific Reports. 11(1). 20 indexed citations
3.
Panel, Mathieu, Isaac Ruiz, Rozenn Brillet, et al.. (2019). Small-Molecule Inhibitors of Cyclophilins Block Opening of the Mitochondrial Permeability Transition Pore and Protect Mice From Hepatic Ischemia/Reperfusion Injury. Gastroenterology. 157(5). 1368–1382. 67 indexed citations
4.
Chobert, Marie-Noële, et al.. (2016). The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway. Scientific Reports. 6(1). 28806–28806. 77 indexed citations
5.
Duval, Caroline, Fatima Teixeira-Clerc, Alix F. Leblanc, et al.. (2016). Chronic Exposure to Low Doses of Dioxin Promotes Liver Fibrosis Development in the C57BL/6J Diet-Induced Obesity Mouse Model. Environmental Health Perspectives. 125(3). 428–436. 95 indexed citations
6.
Mallat, Ariane, et al.. (2014). Autophagy: A Multifaceted Partner in Liver Fibrosis. BioMed Research International. 2014. 1–7. 80 indexed citations
7.
Pierre, Stéphane, Aline Chevallier, Fatima Teixeira-Clerc, et al.. (2013). Aryl Hydrocarbon Receptor–Dependent Induction of Liver Fibrosis by Dioxin. Toxicological Sciences. 137(1). 114–124. 94 indexed citations
8.
Mallat, Ariane, Fatima Teixeira-Clerc, & Sophie Lotersztajn. (2013). Cannabinoid signaling and liver therapeutics. Journal of Hepatology. 59(4). 891–896. 106 indexed citations
9.
Louvet, Alexandre, Fatima Teixeira-Clerc, Marie-Noële Chobert, et al.. (2011). Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology. 54(4). 1217–1226. 205 indexed citations
10.
Deveaux, Vanessa, Thomas Cadoudal, Fatima Teixeira-Clerc, et al.. (2009). Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis. PLoS ONE. 4(6). e5844–e5844. 179 indexed citations
11.
Lotersztajn, Sophie, Fatima Teixeira-Clerc, Vanessa Deveaux, et al.. (2007). CB2 receptors as new therapeutic targets for liver diseases. British Journal of Pharmacology. 153(2). 286–289. 92 indexed citations
12.
Mallat, Ariane, Fatima Teixeira-Clerc, Vanessa Deveaux, & Sophie Lotersztajn. (2007). Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases. Expert Opinion on Therapeutic Targets. 11(3). 403–409. 50 indexed citations
13.
Teixeira-Clerc, Fatima, Pascale Grenard, Jeanne Tran Van Nhieu, et al.. (2007). Le système endocannabinoïde, une nouvelle cible pour le traitement de la fibrose hépatique. Pathologie Biologie. 56(1). 36–38. 9 indexed citations
14.
Lotersztajn, Sophie, Fatima Teixeira-Clerc, Christophe Hézode, et al.. (2007). Le système cannabinoïde : perspectives thérapeutiques au cours des hépatopathies chroniques. Gastroentérologie Clinique et Biologique. 31(3). 255–258. 1 indexed citations
15.
Teixeira-Clerc, Fatima, Boris Julien, Pascale Grenard, et al.. (2006). Les antagonistes du récepteur CB1 des cannabinoïdes : une nouvelle approche pour le traitement de la fibrose hépatique. médecine/sciences. 22. 683–685. 3 indexed citations
16.
Teixeira-Clerc, Fatima, Boris Julien, Pascale Grenard, et al.. (2006). CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nature Medicine. 12(6). 671–676. 420 indexed citations
17.
Julien, Boris, Pascale Grenard, Fatima Teixeira-Clerc, et al.. (2005). Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology. 128(3). 742–755. 382 indexed citations
18.
Lotersztajn, Sophie, Boris Julien, Fatima Teixeira-Clerc, Pascale Grenard, & Ariane Mallat. (2004). HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets. The Annual Review of Pharmacology and Toxicology. 45(1). 605–628. 264 indexed citations
19.
Teixeira-Clerc, Fatima, et al.. (2003). A Cysteine-Linkable, Short Cleavable Photoprobe with Dual Functionality To Explore Protein−Protein Interfaces. Bioconjugate Chemistry. 14(3). 554–562. 6 indexed citations
20.
Teixeira-Clerc, Fatima, Andre Ménèz, & Pascal Kessler. (2002). How Do Short Neurotoxins Bind to a Muscular-type Nicotinic Acetylcholine Receptor?. Journal of Biological Chemistry. 277(28). 25741–25747. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Águeda González‐Rodríguez Breakdown of academic impact, for papers by Zongxian Cao Breakdown of academic impact, for papers by Béla Horváth Breakdown of academic impact, for papers by Giulio Ceolotto Breakdown of academic impact, for papers by Gerhard P. Püschel Breakdown of academic impact, for papers by Philippe Gervois Breakdown of academic impact, for papers by Shivendra D. Shukla Breakdown of academic impact, for papers by Ludger Scheja Breakdown of academic impact, for papers by Mohammed Qatanani Breakdown of academic impact, for papers by Tony Jourdan
Rankless by CCL
2026